Koichiro Sugimura

Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall

A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Chronic Thromboembolic Pulmonary Hypertension

Undiagnosed connective tissue diseases

Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways

A global view of pulmonary hypertension

Chronic thromboembolic pulmonary hypertension

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

Systemic sclerosis

Antithrombotic Therapy for VTE Disease

The natural history of progressive fibrosing interstitial lung diseases

The immune system in atherosclerosis

Updated Clinical Classification of Pulmonary Hypertension

Origin and physiological roles of inflammation

The Effects of Arterial Blood Pressure Reduction on Endocan and Soluble Endothelial Cell Adhesion Molecules (CAMs) and CAMs Ligands Expression in Hypertensive Patients on Ca-Channel Blocker Therapy

Chronic thromboembolic pulmonary hypertension

Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease

The association between heart failure and incident cancer in women: an analysis of the Women's Health Initiative

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Angiotensin-Converting Enzyme Gene Polymorphisms and Prognosis in Chronic Thromboembolic Pulmonary Hypertension

Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2

Extracorporeal Shock Wave Therapy as a New and Non-invasive Angiogenic Strategy

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

Gender Differences in Chronic Thromboembolic Pulmonary Hypertension in Japan

Chronic Thromboembolic Pulmonary Hypertension

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Wound Healing: A Cellular Perspective

High Pressure Promotes Monocyte Adhesion to the Vascular Wall

Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease

Global burden of heart failure: a comprehensive and updated review of epidemiology

Endothelial Functions

Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study

Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1

High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis

Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients With Coronary Artery Disease

Intensive Immunosuppressive Therapy Improves Pulmonary Hemodynamics and Long-Term Prognosis in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension

Percutaneous Transluminal Pulmonary Angioplasty Markedly Improves Pulmonary Hemodynamics and Long-Term Prognosis in Patients With Chronic Thromboembolic Pulmonary Hypertension

Potential Risk Factors and Incidence of Pulmonary Thromboembolism in Japan Results From an Overview of Mailed Questionnaires and a Matched Case - Control Study

The upregulation of ICAM-1 and P-selectin requires high blood pressure but not circulating renin–angiotensin system in vivo

Platelets Are Highly Activated in Patients of Chronic Thromboembolic Pulmonary Hypertension

Protective Roles of Endothelial AMP-Activated Protein Kinase Against Hypoxia-Induced Pulmonary Hypertension in Mice

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension